Capital Bluecross Prior Authorization Lookup
Latest Capital Bluecross prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-07-01Allergy Testing and ImmunotherapyPolicy governing medical necessity, quantity limits, investigational status, coding, and prior authorization requirements for allergy diagnostic testing and immunotherapy services for Capital Bluecross members and applicable products; affects providers ordering or administering allergy tests and immunotherapy.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01External Infusion Pumps for Insulin Delivery and Automated Insulin Delivery SystemsGoverns medical necessity and coverage criteria for external insulin infusion pumps and FDA-cleared automated insulin delivery (AID) systems for individuals with diabetes, including indications, replacement rules, device classifications, and documentation required for prior authorization.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaClinical coverage policy for autologous and allogeneic hematopoietic cell transplantation (HCT) for childhood and adult acute lymphoblastic leukemia (ALL), specifying when HCT is considered medically necessary and outlining risk stratification and conditioning considerations for providers and prior authorization reviewers.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Capital Blue Cross Advantage FormularyAdvantage Formulary listing of covered prescription drugs, tier assignments, specialty designation, and utilization management indicators (Prior Authorization, Step Therapy, Quantity Level Limits, PHC, Limited Distribution). This fragment includes Anti‑Infective Agents (Penicillins/Cephalosporins/Macrolides) and supporting formulary development and program rules.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Diabetic Testing Supplies Prior Authorization Criteria (Medicare Part B)All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Diabetic Testing Supplies Prior Authorization Criteria Medicare Part BDefines Capital Blue Cross Medicare Part B prior authorization requirements for diabetic testing supplies (test strips, lancets, meters) and identifies preferred vs nonpreferred products; applies to providers and Medicare Part B members.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Diabetic Testing Supplies Prior Authorization Criteria — Medicare Part BAll Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2025-05-01Cosmetic and Reconstructive Surgery (Coverage Criteria)Defines when surgical and related procedures are reconstructive (medically necessary) versus cosmetic or investigational, lists specific services and required documentation, and notes product-specific prior authorization and benefit variations.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2025-01-01Isolated Small Bowel Transplant and Small Bowel–Liver and Multivisceral TransplantDefines medical necessity, investigational indications, and candidate/contraindication considerations for isolated small bowel transplant and combined small bowel–liver or multivisceral transplant for adults and pediatrics dependent on long-term total parenteral nutrition (TPN). Affects Capital BlueCross members and provider prior authorization/coverage decisions.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyEff. 2024-10-01Negative Pressure Wound Therapy in the Outpatient SettingThis policy governs when initiation and continuation of powered NPWT in the outpatient setting are considered medically necessary or investigational for Capital Bluecross members; it applies to clinicians and prior authorization reviewers involved in outpatient wound care.All Capital Bluecross updates
- Prior AuthReimbursement/Payment PolicyEff. 2020-09-01Blenrep® (belantamab mafodotin-blmf)This policy governs prior authorization and coverage stance for the intravenous oncology drug Blenrep for members of Capital Bluecross; it applies to requests for Blenrep and outlines medical necessity and billing information.All Capital Bluecross updates
- Prior AuthClinical/Medical Policy2026 Exclusive Full DRUG LIST (Formulary)Capital Blue Cross Exclusive Full Formulary listing covered prescription drugs, tier placement, specialty designation, and utilization management indicators (prior authorization, step therapy, quantity limits, limited distribution) for fully insured individual and employer group plans in Pennsylvania.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyAduhelm (aducanumab-avwa) (Intravenous) Coverage CriteriaThis policy governs coverage and prior authorization for Aduhelm (aducanumab-avwa) intravenous treatment and states the payer's stance on its medical necessity for Alzheimer's disease and related indications.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyApplied Behavior Analysis (ABA) Preauthorization Request FormThis document is a preauthorization request form used by providers to request initial assessment, initial treatment, or continued ABA treatment for members with autism spectrum disorder and to submit required clinical documentation to Capital BlueCross.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyContinuous Glucose Monitor (CGM) prior authorizationDefines prior authorization requirements for Continuous Glucose Monitors (CGMs) for Capital Blue Cross beneficiaries, including clinical criteria, preferred devices, and approval duration. Applies to providers requesting coverage for CGM systems for members covered by Capital Blue Cross.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyContinuous Glucose Monitors (CGMs) — Prior Authorization and Benefit LimitsGoverns prior authorization criteria and member benefit limits for Continuous Glucose Monitors (receivers, transmitters, sensors, readers/monitors) and associated NDC/GPI lists for Capital Bluecross members in NC.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyDiabetic Blood Glucose Test Strips and Cartridges Prior AuthorizationThis document governs prior authorization review for diabetic testing supplies (blood glucose test strips and cartridges) when a requested amount exceeds the program benefit limit. It affects prescribers, pharmacists, and members covered by Capital Bluecross in the specified jurisdiction.All Capital Bluecross updates
- Prior AuthAdministrative/Operational PolicyPreauthorization for inpatient elective admissionThis document governs preauthorization requirements for inpatient and observation hospital admissions for Capital Blue Cross members, specifying when prior authorization is required and how to submit requests; it affects providers requesting inpatient elective admissions and related services.All Capital Bluecross updates
- Prior AuthAdministrative/Operational PolicyPreauthorization for inpatient elective admissionThis document is a Capital Blue Cross preauthorization form and instructions for requesting prior authorization for non-emergent (elective) inpatient admissions; it affects providers submitting authorization requests for members covered by Capital Blue Cross products in North Carolina and other listed products. It describes required member, clinical, and provider information and submission instructions.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyPrescription Drug Formulary and Utilization ManagementThis document governs the Capital Blue Cross Elite Full Formulary: which drugs are covered, tier placement, and utilization management (prior authorization, step therapy, quantity limits) for members and providers under Capital Blue Cross plans.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyRepetitive Transcranial Magnetic Stimulation (rTMS) Request Form and Clinical CriteriaThis document is a preauthorization request form and clinical criteria checklist governing rTMS treatment requests for Capital Blue Cross members, used by providers to document diagnosis, prior treatments, and medical necessity for coverage decisions.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyValue Formulary (2026) — Prescription Drug List and Utilization ManagementDefines the Capital Blue Cross 2026 Value Formulary for prescription drugs, including formulary tiers, specialty drug handling, utilization management (prior authorization, step therapy, quantity limits), and processes for exceptions and reconsideration; applies to members and providers under Capital Blue Cross plans governed by this formulary.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyValue Plus Formulary — Prescription Drug Coverage and Utilization ManagementGoverns coverage, utilization management, and pharmacy benefit administration for Capital BlueCross Value Plus formulary members, including prior authorization, step therapy, quantity limits, specialty drug distribution, and nonformulary exception processes. Affects providers, pharmacists, and members covered under Capital BlueCross prescription drug plans.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyValue Plus Formulary — Prescription Drug Formulary and Utilization ManagementGoverns Capital Blue Cross's Value Plus prescription drug formulary, utilization management (prior authorization, step therapy, quantity limits), specialty drug distribution, and related pharmacy procedures for members and providers.All Capital Bluecross updates
- Prior AuthClinical/Medical PolicyContinuous Glucose Monitor (CGM) prior authorizationAll Capital Bluecross updates
Tool Description
Search Capital Bluecrossprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.